Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 12:03 PM
Ignite Modification Date:
2025-12-24 @ 12:03 PM
NCT ID:
NCT05768061
Eligibility Criteria:
Inclusion Criteria:
* subjects (men and women) of age 18 and above, who received anti-CD20 (Rituximab) drugs as a treatment for a variety of diseases .
Exclusion Criteria:
* healthy subjects.
* subjects under the age 18.
* subjects who did not receive anti CD20
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT05768061
Study Brief:
Protocol Section:
NCT05768061